pre-ipo
Stage
About
Oricell Therapeutics is a clinical-stage biotechnology company developing innovative CAR-T cell therapies targeting cancers such as liver cancer and multiple myeloma, with multiple ongoing clinical trials in China and the US.
Explore Oricell Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.